Author Information
Koji Abe is a prominent researcher in the field of neurology, affiliated with the Department of Neurology at the Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama University, located in Okayama, Japan. His work primarily focuses on neurodegenerative diseases, neuroprotection, and stroke, contributing significantly to our understanding of these conditions through both clinical and experimental studies.Research Contributions
Koji Abe has made extensive contributions to the field of neurology, with a particular focus on neurodegenerative diseases such as Alzheimer's disease and amyotrophic lateral sclerosis (ALS). In 2022, his research explored topics like the mutation screening of the DNAJC7 gene in Japanese patients with sporadic ALS and the neuroprotective effects of various compounds in models of Alzheimer's disease. His work also delves into innovative therapeutic approaches, such as the use of plasmalogen, Tocovid, and Twendee-X, and the effects of Rivaroxaban in Alzheimer's disease models. Abe's studies are notable for their integration of both clinical insights and laboratory research, providing a comprehensive understanding of neurological disorders.Aliases
Throughout his academic career, Koji Abe has been cited under various aliases, including K Abe, K. Abe, and Kōji Abe. These variations reflect the different transliterations and abbreviations of his name in scientific publications.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
19,003 |
| H-index |
64 |
| Paper Count |
846 |
